← Back to headlines
Soleno Therapeutics GAAP EPS of $0.80 beats by $0.09, revenue of $91.73M beats by $3.18M
Soleno Therapeutics reported GAAP EPS of $0.80, beating estimates by $0.09, and revenue of $91.73 million, surpassing estimates by $3.18 million.
25 Feb, 22:13 — 25 Feb, 22:13
Sources
Showing 1 of 1 sources
Related Stories
The OLB Group Reports Q2 Financials; FinVolution Group to Announce Results
41m ago
Mark Cuban and Tech Founders Oppose California Wealth Tax Proposal
3h ago
Greece to Save €2 Billion by Early Debt Repayment in 2026
4h ago
SEC Proposal Would Allow Companies to Announce Earnings Quarterly, Ditch Filings
5h ago